Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

RUMENSIN CRC DIN 02082128

Status: Cancelled Post Market
Holder: ELANCO CANADA LIMITED
Molecule: MONENSIN (MONENSIN SODIUM)

Health Canada record

Active ingredient(s)MONENSIN (MONENSIN SODIUM) 32 G
Dosage formCapsule (Extended-Release)
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date31-Dec-1994
Current status date19-Jul-2019
SourceHealth Canada DPD

Establishment licence of the holder

Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MONENSIN (MONENSIN SODIUM)

DINProductCompanyFormStrengthStatus
02231172COBAN PREMIXELANCO CANADA LIMITEDDrug PremixMONENSIN (MONENSIN SODIUM) 200 GMarketed
02451999KEXXTONEELANCO CANADA LIMITEDCapsuleMONENSIN (MONENSIN SODIUM) 32.4 GMarketed
02243232MONENSIN PREMIXBIO AGRI MIX LPDrug PremixMONENSIN (MONENSIN SODIUM) 200 GMarketed
02516772MONOVETHUVEPHARMA EOODDrug PremixMONENSIN (MONENSIN SODIUM) 200 GMarketed
02231173RUMENSIN PREMIXELANCO CANADA LIMITEDDrug PremixMONENSIN (MONENSIN SODIUM) 200 GMarketed

Notices of Compliance

NOCDateSubmissionReason
203592018-01-18New Drug Submission (NDS)MERGER - BUYOUT
112852010-04-22Supplement to a New Drug Submission (SNDS)Additional claim
104052009-07-20Supplement to a New Drug Submission (SNDS)Additional warning statement
100862009-03-11Supplement to a New Drug Submission (SNDS)New capsule design
96812008-07-16Supplement to a New Drug Submission (SNDS)ADDITIONAL CLAIM
36472004-02-20New Drug Submission (NDS)
65052000-02-02Supplement to a New Drug Submission (SNDS)AS AN AID IN THE PREVENTION OF COCCIDIOSIS CAUSED BY EIMERIA ZUERNII AND E. BOVIS IN CATTLE WEIGHING UP TO 350KG
68251997-11-24Supplement to a New Drug Submission (SNDS)NEW INDICATION
75021994-03-25New Drug Submission (NDS)
Request a quote for RUMENSIN CRC

How to read a Canadian DIN record